Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
190
datasets available to search
ShareScore release 0.9.0
Dataset results
190 results for “Population-based”
Data from: A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area
Open the record for dataset details and reuse information.
Data from: Novel methods to define invasive procedures at the end-of-life were developed to improve quality of end of life care research: A population-based cohort study in colorectal cancer
Open the record for dataset details and reuse information.
Simulated population time series used to build and test a model of accuracy for population-based global biodiversity indicators
Open the record for dataset details and reuse information.
Risk factors for non-communicable diseases in Bangladesh: Findings of the population-based cross-sectional national survey 2018
Open the record for dataset details and reuse information.
Population-based heteropolymer design to mimic protein mixtures
Open the record for dataset details and reuse information.
Data from: Statin use and cognitive function: population-based observational study with long-term follow-up
We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0–10; high performance, 11–12 points) in an observational study that included 4,095 community-dwelling participants aged 35–82 years. Data on statin use were obtained from a computerized pharmacy database. Analysis were done for the total cohort and subsamples matched on cardiovascular risk (N = 1232) or propensity score for statin use (N = 3609). We found that a total of 904 participants (10%) used a statin. Statin users were older than non-users: mean age (SD) 61 (10) vs. 52 (11) years (p<0.001). The median duration of statin use was 3.8 (interquartile range, 1.6–4.5) years. Unadjusted, statin users had worse cognitive performance than non-users. The mean RFFT score (SD) in statin users and non-users was 58 (23) and 72 (26) points, respectively (p<0.001). VAT performance was high in 261 (29%) statin users and 1351 (43%) non-users (p<0.001). However, multiple regression analysis did not show a significant association of RFFT score with statin use (B, −0.82; 95%CI, −2.77 to 1.14; p = 0.41) nor with statin solubility, statin dose or duration of statin use. Statin users with high doses or long-term use had similar cognitive performance as non-users. This was found in persons with low as well as high cardiovascular risk, and in younger as well as older subjects. Also, the mean RFFT score per quintile of propensity score for statin use was comparable for statin users and non-users. Similar results were found for the VAT score as outcome measure. In conclusion, statin use was not associated with cognitive function. This was independent of statin dose or duration of statin use.
Data from: Integration of Random Forest with population-based outlier analyses provides insight on the genomic basis and evolution of run timing in Chinook salmon (Oncorhynchus tshawytscha)
Anadromous Chinook salmon populations vary in the period of river entry at the initiation of adult freshwater migration, facilitating optimal arrival at natal spawning. Run timing is a polygenic trait that shows evidence of rapid parallel evolution in some lineages, signifying a key role for this phenotype in the ecological divergence between populations. Studying the genetic basis of local adaptation in quantitative traits is often impractical in wild populations. Therefore, we used a novel approach, Random Forest, to detect markers linked to run timing across 14 populations from contrasting environments in the Columbia River and Puget Sound, USA. The approach permits detection of loci of small effect on the phenotype. Divergence between populations at these loci was then examined using both principle component analysis and FST outlier analyses, to determine whether shared genetic changes resulted in similar phenotypes across different lineages. Sequencing of 9107 RAD markers in 414 individuals identified 33 predictor loci explaining 79.2% of trait variance. Discriminant analysis of principal components of the predictors revealed both shared and unique evolutionary pathways in the trait across different lineages, characterized by minor allele frequency changes. However, genome mapping of predictor loci also identified positional overlap with two genomic outlier regions, consistent with selection on loci of large effect. Therefore, the results suggest selective sweeps on few loci and minor changes in loci that were detected by this study. Use of a polygenic framework has provided initial insight into how divergence in a trait has occurred in the wild.
Data from: Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study
Objective. Type 2 diabetes mellitus is increasing in young adults, and greater adiposity is considered a major risk factor. However, whether there is an association between obesity and diabetes and how this might be impacted by age is not clear. Therefore, we investigated the association between body mass index (BMI) and diabetes across a wide range of age groups (20-30, 30-40, 40-50, 50-60, 60-70, ≥70 years old). Design. We performed a retrospective cohort study using healthy screening program data. Setting. A total of 211,833 adult Chinese persons > 20-years-old across 32 sites and 11 cities in China (Shanghai, Beijing, Nanjing, Suzhou, Shenzhen, Changzhou, Chengdu, Guangzhou, Hefei, Wuhan, Nantong) were selected for the study; these persons were free of diabetes at baseline. Primary and secondary outcome measures. Fasting plasma glucose levels were measured and information regarding the history of diabetes was collected at each visit. Diabetes was diagnosed as fasting plasma glucose ≥ 7.00 mmol/L and/or self-reported diabetes. Patients were censored at the date of diagnosis or the final visit, whichever came first. Results. With a median follow-up of 3.1 years, 4,174 of the 211,833 participants developed diabetes, with an age-adjusted incidence rate of 7.35 per 1,000 persons. The risk of incident diabetes increased proportionally with increasing baseline BMI values, with a 23% increased risk of incident diabetes with each kg/m2 increase in BMI (95%CI: 1.22, 1.24). Across all age groups, there was a linear association between BMI and the risk of incident diabetes, although there was a stronger association between BMI and incident diabetes in the younger age groups (age × BMI interaction, P < 0.0001). Conclusions. An increased BMI is also independently associated with a higher risk of developing diabetes in young adults and the effects of BMI on incident diabetes were accentuated in younger adults.
Data from: Out-of-hospital endotracheal intubation experience, confidence, and confidence-associated factors among Northern Japanese emergency life-saving technicians: a population-based cross-sectional study
Objective: Clinical procedural experience and confidence are both important when performing complex medical procedures. Because out-of-hospital endotracheal intubation (ETI) is a complex intervention, we sought to clarify clinical ETI experience among prehospital rescuers as well as their confidence in performing ETI and confidence-associated factors. Design: Population-based cross-sectional study conducted from January to September 2017. Setting: Northern Japan, including eight prefectures. Participants: Emergency life-saving technicians (ELSTs) authorized to perform ETI. Outcome measures: Annual ETI exposure and confidence in performing ETI, according to a 5-point Likert scale. To determine factors associated with ETI confidence, differences between confident ELSTs (those scoring 4 or 5 on the Likert scale) and non-confident ELSTs were evaluated. Results: Questionnaires were sent to 149 fire departments; 140 agreed to participate. Among the 2821 ELSTs working at responding fire departments, 2620 returned the questionnaire (response rate, 92.9%); complete data sets were available for 2567 ELSTs (complete response rate, 91.0%). Of those 2567 respondents, 95.7% performed two or fewer ETI annually; 46.6% reported lack of confidence in performing ETI. Multivariable logistic regression analysis showed that years of clinical experience (adjusted odds ratio [AOR], 1.09; 95% confidence interval [CI], 1.05–1.13), annual ETI exposure (AOR, 1.79; 95% CI, 1.59–2.03), and the availability of ETI skill retention programs including regular simulation training (AOR, 1.31; 95% CI, 1.02–1.68) and operating room training (AOR, 1.44; 95% CI, 1.14–1.83) were independently associated with confidence in performing ETI. Conclusions: ETI is an uncommon event for most ELSTs and nearly half of respondents did not have confidence in performing this procedure. Because confidence in ETI was independently associated with availability of regular simulation and operating room training, standardization of ETI reeducation that incorporates such methods may be useful for prehospital rescuers.
Data from: Complementary and alternative asthma treatments and their association with asthma control: a population-based study
Objectives: Many patients with asthma spend time and resources consuming complementary and alternative medicines (CAMs). This study explores whether CAM utilization is associated with asthma control and the intake of asthma controller medications. Design: Population-based, prospective cross-sectional study Setting: general population residing in two census areas in the province of British Columbia, Canada. Recruitment was based on random-digit dialing of both landlines and cell phones. Participants: 486 patients with self-reported physician-diagnosis of asthma (mean age 52 years; 67.3% female). Primary and secondary outcome measures: We assessed CAM use over the previous 12 months, level of asthma control as defined by the Global Initiative for Asthma (GINA), and the self-reported intake of controller medications. Multivariate logistic regression was performed to study the relationship between any usage of CAMs (outcome), asthma control and controller medication usage, adjusted for potential confounders. Results: A total of 179 (36.8%) of the sample reported CAM usage in the past 12 months. Breathing exercises (17.7%), herbal medicines (10.1%), and vitamins (9.7%) were the most popular CAMs reported. After adjustment, female sex (OR: 1.66; 95% CI: 1.09-2.52) and uncontrolled asthma( vs. controlled asthma, OR: 2.25, 95% CI: 1.30-3.89) were associated with a higher likelihood of using any CAMs in the past 12 months. Controller medication use was not associated with CAM usage in general and in the subgroups defined by asthma control. Conclusion: Clinicians and policy makers need to be aware of the high prevalence of CAM use in patients with asthma and its association with lack of asthma control.
Data from: The burden of Hepatitis C virus infection in Punjab, India: a population-based serosurvey
Introduction: Hepatitis C virus (HCV) infection prevalence is believed to be elevated in Punjab, India; however, state-wide prevalence data are not available. An understanding of HCV prevalence, risk factors and genotype distribution can be used to plan control measures in Punjab. Methods: A cross-sectional, state-wide, population-based serosurvey using a multi-stage stratified cluster sampling design was conducted October 2013 to April 2014. Children aged >5 years and adults were eligible to participate. Demographic and risk behavior data were collected, and serologic specimens were obtained and tested for anti-HCV antibody, HCV Ribonucleic acid (RNA) on anti-HCV positive samples, and HCV genotype. Prevalence estimates and adjusted odds ratios for risk factors were calculated from weighted data and stratified by urban/rural residence. Results: 5,543 individuals participated in the study with an overall weighted anti-HCV prevalence of 3.6% (95% Confidence Interval [CI]: 3.0%-4.2%) and chronic infection (HCV Ribonucleic acid test positive) of 2.6% (95% CI: 2.0%-3.1%). Anti-HCV was associated with being male (adjusted odds ratio 1.52; 95% CI: 1.08-2.14), living in a rural area (adjusted odds ratio 2.53; 95% CI: 1.62-3.95) and was most strongly associated with those aged 40-49 (adjusted odds ratio 40-49 vs 19-29-year-olds 3.41; 95% CI: 1.90-6.11). Anti-HCV prevalence increased with each blood transfusion received (adjusted odds ratio 1.36; 95% CI: 1.10-1.68) and decreased with increasing education, (adjusted odds ratio 0.37 for graduate-level vs. primary school/no education; 95% CI: 0.16-0.82). Genotype 3 (58%) was most common among infected individuals. Discussion: The study findings, including the overall prevalence of chronic HCV infection, associated risk factors and demographic characteristics, and genotype distribution can guide prevention and control efforts, including treatment provision. In addition to high-risk populations, efforts targeting rural areas and adults aged >40 would be the most effective for identifying infected individuals.
Appendix of Integrating Population-based Patterns with Personal Routine to Re-engage Fitbit Use
<p>Appendix of Integrating Population-based Patterns with Personal Routine to Re-engage Fitbit Use</p>
Supplemental Materials - Performance Figures for "A Model for Predicting the (re)-occurrence of a ≥40% eGFR Decline in a large Population-based cohort of Persons with or At-Risk of Chronic Kidney Disease " paper
<p>The zip file contains performance metrics figures for each dynamic Bayesian Network (DBN) model, stratified by comorbidities, race, CKD stages, and ethnicity.</p> <p>Contains:</p> <ul> <li>Stratified: Bootstrapping of 1000 iterations and 1000 samples with stratified proportions (as in the original population of the test set) of rapid eGFR decliners and non-decliners.</li> </ul> <p> </p> <p>Second zip contains DBN structures as matrices for 2 periods study entry to entry period and entry period to year 1 for all sites in 2 excel files.</p>
COLSCREEN: 16S-sequencing of fecal microbiota from a population-based CRC screening program
<p><span>The research cohort (COLSCREEN study) was recruited among individuals that participated during 2016-2020 in the ongoing population-based CRC screening program overseen by the Catalan Institute of Oncology in L’Hospitalet del Llobregat, Barcelona, Spain. This program invites men and women between the ages of 50 and 69 to partake in the immunochemical fecal occult blood test (FIT). In the event of a positive FIT result (≥ 20 μg Hb/g feces), the participants are then recommended to undergo colonoscopy. Participants of the COLSCREEN study (N=997) were invited to participate after receiving a positive FIT result. Since CRC diagnosis is rare in screening, this cohort includes patients diagnosed clinically from the CRC Functional Unit (N=45). Furthermore, a subset of participants with a negative FIT is also included (N=140). All of them underwent a colonoscopy and participants were categorized based on the risk stratification proposal by Castells et al. after careful review of the colonoscopy and histopathology reports. All participants who agreed to take part of the COLSCREEN study provided written informed consent and donated a fecal and blood sample at recruitment (samples obtained before colonoscopy) and answered an epidemiological questionnaire. Clinically diagnosed CRC patients usually underwent a colonoscopy before recruitment, and the fecal samples were obtained prior surgery. In the present study, we excluded those participants that reported having used antibiotics or probiotics one month before sampling. </span></p>
Population-based Age-stratified Seroprevalence Investigation on SARS-CoV-2 Virus in Selected States of High and Low Burden of Disease in Nigeria
<p>Results of population-based age stratified seroepidemiological investigation in Nigeria</p>
Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection in Kyrgyz Republic
<p>Results of population-based age stratified seroepidemiological investigation in Kyrgyzstan.</p>
Population-based seroepidemiological investigation for coronavirus 2019 (COVID-19) infection in Cox's Bazar Rohingya camps
<p>Population-based age stratified seroepidemiological investigation in Bangladesh</p>
Population-based Age-Stratified Seroepidemiological Investigation for Coronavirus 2019 (COVID-19) Infection in Indonesia
<p>Results of population-based age stratified seroepidemiological investigation in Indonesia</p>
Impacts of using different standard populations in calculating age-standardized death rates when age-specific death rates in the populations being compared do not have a consistent relationship: A cross-sectional population-based observational study on US state HIV death rates
<p><strong>Objective</strong>: To examine if the rankings of state HIV age-standardized death rates (ASDRs) changed if different standard population (SP) was used.</p> <p><strong>Design</strong>:<strong> </strong>A cross-sectional population-based observational study. Setting 36 states in the United States.</p> <p><strong>Participants</strong>: People died from 2015 to 2019.</p> <p><strong>Main outcome measures</strong>: State HIV ASDR using 4 SPs, namely WHO2000, US2000, US2mor020, and Eur2011–2030.</p> <p><strong>Results</strong>: The rankings of 19 states did not change when ASDRs were calculated using US2000 and US2020. Of the 17 states whose rankings changed, the rankings of 9 states calculated using US2000 were higher than those calculated using US2020; in 8 states, the rankings were lower. The states with the greatest changes in rankings between US2000 and US2020 were Kentucky (12th and 9th, respectively) and Massachusetts (8th and 11th, respectively).</p> <p><strong>Conclusions</strong>: State ASDRs calculated using the current official SP (US2000) weigh middle-age HIV death rates more heavily than older-age HIV death rates, resulting in lower ASDRs among states with higher older-age HIV death rates.</p>
Data used for analysis in "Calibrating tropical forest coexistence in ecosystem demography models using multi-objective optimization through population-based parallel surrogate search"
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.